Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail

Over the last months, due to coronavirus disease (COVID-19) pandemic, containment measures have led to important social restriction. Healthcare systems have faced a complete rearrangement of resources and spaces, with the creation of wards devoted to COVID-19 patients. In this context, patients affe...

Full description

Saved in:
Bibliographic Details
Published in:Neurological sciences 2021-01, Vol.42 (1), p.9-13
Main Authors: Bombaci, Alessandro, Abbadessa, Gianmarco, Trojsi, Francesca, Leocani, Letizia, Bonavita, Simona, Lavorgna, Luigi
Format: Article
Language:English
Subjects:
Amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis - diagnosis
Amyotrophic Lateral Sclerosis - therapy
Coronaviruses
COVID-19
Humans
Medicine
Medicine & Public Health
Monitoring, Ambulatory
Morbidity
Neurological diseases
Neurology
Neuroradiology
Neurosciences
Neurosurgery
Pandemics
Psychiatry
Severity of Illness Index
Telemedicine
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Over the last months, due to coronavirus disease (COVID-19) pandemic, containment measures have led to important social restriction. Healthcare systems have faced a complete rearrangement of resources and spaces, with the creation of wards devoted to COVID-19 patients. In this context, patients affected by chronic neurological diseases, such as amyotrophic lateral sclerosis (ALS), are at risk to be lost at follow-up, leading to a higher risk of morbidity and mortality. Telemedicine may allow meet the needs of these patients. In this commentary, we briefly discuss the digital tools to remotely monitor and manage ALS patients. Focusing on detecting disease progression and preventing life-threatening conditions, we propose a toolset able to improve ALS management during this unprecedented situation.
ISSN:1590-1874
1590-3478
DOI:10.1007/s10072-020-04783-x